Therapeutic effects of metabolic cardioprotector containing L-arginine and inosine in elderly patients with ischemic heart disease

Abstract

Research of an oxidative stress, antioxidant systems, function of vascular endothelium and episodes of myocardial ischemia in 121 elderly patients with IHD (average age 78,75±0,62 years) was performed. Recovery of endothelium-depended vasodilatation, improvement of indexes of nitric oxide metabolism, oxidative stress reduction, decrease of duration and expressiveness of episodes of myocardial ischemia during treatment by metabolic cardioprotector as a part of complex therapy throughout 3 months in these patients were shown.

Keywords

• endothelial dysfunction
• oxidative stress
• myocardial ischemia
• metabolic cardioprotector